5 new weight-loss drugs to watch in fight for next Ozempic
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
Go on, give it a shot. Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition ...
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...
Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback